Cell therapy market is a technology that relies on replacing diseased or dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, owing to their ability to differentiate into specific cells required for repairing damaged or defective tissues or cells.
Moreover, cell therapy finds its application in development of regenerative medicines, which is a multidisciplinary area aimed at maintenance, improvement, or restoration of cell, tissue, or organ function using methods mainly related to cell therapy. In addition, cells such as blood and bone marrow cells, mature, immature & solid tissue cells, adult stem cells, and embryonic stem cells are widely used in cell therapy procedures.
Moreover, transplanted cells including induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs), neural stem cells (NSCs), and mesenchymal stem cells (MSCs) are divided broadly into two main groups including autologous cell therapy and non-autologous cell therapy.
Global Cell Therapy Market: Overview
The global cell therapy market accounted for $7.8 billion in 2020 and is expected to reach $30.21 billion by 2030, registering a CAGR of 14.50%.
Rise in adoption of human cells for cell therapeutics research, technological advancements in field of cell therapy, and increase in incidences of diseases such as cancer and cardiac abnormalities are the key factors that drive growth of the market.
Furthermore, implementation of stringent government regulations regarding the use of cell therapy is anticipated to restrict the growth of this market.
On the contrary, surge in number of regulations to promote stem cell therapy and increase in funds for research in developing countries are expected to offer lucrative opportunities for the market in the future.
Get Exclusive Sample Copy of This Report Here: https://crediblemarkets.com/sample-request/global-cell-therapy-market-621763
Based on Cell Type
Stem Cell
Bone Marrow
Blood
Umbilical Cord-Derived
Adipose-Derived Stem Cell
Others (placenta, and nonspecific cells)
Non-Stem Cell
Based on Therapy Type
Autologous
Allogeneic
Based on Therapeutic Type
Malignancies
Musculoskeletal Disorders
Autoimmune Disorders
Dermatology
Others
Based on End-User
Hospitals & Clinics
Academic & Research Institutes
Based on Region
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Spain
Italy
Asia-Pacific
Japan
India
China
Australia
LAMEA
UAE
Saudi Arabia
South Africa
North America commanded the largest share of the cell therapy technologies market. The large share of this market segment can be attributed to the increasing incidence of CVD, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region.
Competitive Landscape:
ALLOSOURCE
CELLS FOR CELLS
HOLOSTEM TERAPIE AVANZATE SRL
JCR PHARMACEUTICALS CO., LTD.
KOLON TISSUEGENE, INC.
MEDIPOST CO., LTD.
MESOBLAST LTD
NUVASIVE, INC.
OSIRIS THERAPEUTICS, INC.
STEMEDICA CELL TECHNOLOGIES, INC
Major Developments:
- In 2020, Lonza (Switzerland) collaborated with IsoPlexis (US) to develop the next generation of precision cell therapy manufacturing.
- In 2020, Biopharma business from General Electric Company’s Life Sciences division (US) Danaher acquired the Biopharma business from General Electric Company’s Life Sciences division. The acquisition led to a new business named Cytiva, a standalone operating company within Danaher’s Life Sciences segment.
Key Trends: Growth Determinants and Challenges
Inception of effective guidelines for cell therapy manufacturing, development of advanced genomic analysis techniques, vast number of researches by cancer societies, and proven effectiveness of transplants are some of the primary growth factors of the cell therapy market.
Furthermore, increase in financing and investments to support launch of new companies is expected to boost organic revenue growth of the market.
Rise in prevalence of population suffering from cardiovascular, cancer, and other diseases is expected to positively affect growth of the market.
Moreover, increase in initiatives taken by authorities and governments to improve healthcare systems and spread awareness regarding benefits of cell therapy are also expected to increase growth of the global market.
Buy This Latest Premium Report Now: https://crediblemarkets.com/reports/purchase/global-cell-therapy-market-621763?utf8=%E2%9C%93&license_type=single_user
Key Takeaways from the report:
- Deep-insights on regional analysis of this market.
- Top companies and growth factors of the global cell therapy market.
- The global cell therapy market accounted for $7.8 billion in 2020 and is expected to reach $30.21 billion by 2030, registering a CAGR of 14.50%.
Major questions answered in the report:
- What are the growth opportunities in the cell therapy technologies market across major regions in the future?
- What are the top companies contributing in the growth of global cell therapy market?
- Which segment holds the largest share in the global cell therapy market?
About US
Credible Markets has emerged as a dependable source for the market research needs of businesses within a quick time span. We have collaborated with leading publishers of market intelligence and the coverage of our reports reserve spans all the key industry verticals and thousands of micro markets. The massive repository allows our clients to pick from recently published reports from a range of publishers that also provide extensive regional and country-wise analysis. Moreover, pre-booked research reports are among our top offerings.
The collection of market intelligence reports is regularly updated to offer visitors ready access to the most recent market insights. We provide round-the-clock support to help you repurpose search parameters and thereby avail a complete range of reserved reports. After all, it is all about helping you reach an informed strategic decision about purchasing the right report that caters to all your market research demands.
Reports in the repository of Credible Markets leverage predictive analytical models to study the performance of critical market segments. We believe in the fact that demands of businesses depend on an array of parameters and thus adhere to delivering industry-specific research solutions. Our client base traversing from thriving start-ups to some of the Fortune 500 companies speaks for our expertise in providing deep-dive insights on any desired industry sectors.
Contact Us
Credible Market Analytics
99 Wall Street 2124 New York, NY 10005
Email: sales@crediblemarkets.com
